BioDelivery Sciences International, Inc.
Head Quarters
Suite 225 4131 ParkLake Avenue USWebsite
http://www.bdsi.comIndustry
PharmaceuticalsOtherEmployees
99Exchange
NASDAQBioDelivery Sciences International, Inc. operates as a pharmaceutical company, which engages in the development and commercialization of new applications of approved therapeutics to address important unmet medical needs. It focuses on pharmaceutical products in the areas of pain management and addiction. The company was founded on January 6, 1997 and is headquartered in Raleigh, NC.
Key statistics
| Margins | Stock |
|---|---|
| Revenue per Employee | $0.00 |
| Current Ratio | 1 |
| Gross Margin (%) | 0.66% |
| Net Margin (%) | 1.17% |
| Returns | Stock |
| Sales | $41.00M |
| Sales Growth (% qtr vs. yr ago) | 0.00% |
| Net Income | -$9.00M |
| NI Growth (% qtr vs. yr ago) | 0.00% |
| Price/Sales | 10.61 |
| EPS | $0.00 |